Craig Dais - 10 Nov 2023 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Gioia Gentile for Craig Dais by power of attorney
Issuer symbol
N/A
Transactions as of
10 Nov 2023
Net transactions value
$0
Form type
4
Filing time
14 Nov 2023, 16:38:55 UTC
Previous filing
15 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +973,633 $0.000000 973,633 10 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of stock vest in two tranches: 50% vest upon the date of the grant and the remaining 50% shall vest upon the one-year anniversary of the grant date, subject to Mr. Dais' continued employment with the Company.